30
Participants
Start Date
July 31, 2008
Primary Completion Date
August 31, 2008
r-hGH liquid (Saizen)
Treatment Arm A: r-hGH liquid multidose formulation 5.83 mg/mL, needle injection (0.686 mL)
r-hGH liquid (Saizen)
Treatment Arm B: r-hGH liquid multidose formulation 8.0 mg/mL, needle injection (0.5 mL)
r-hGH freeze-dried
Treatment Arm C: r-hGH 8 mg (8.8 mg/1.51 ml) freeze-dried formulation ( reconstituted in metacresol 0.3% w/v) needle injection (0.686 mL)
AAI Pharma Deutschland GmbH & Co. KG, Neu-Ulm
Lead Sponsor
EMD Serono
INDUSTRY